TY - JOUR
T1 - Autoantibodies Against Ubiquitous and Confined Antigens in Patients With Ocular, Neuro-Ophthalmic and Congenital Cerebral Toxoplasmosis
AU - Goldberg-Murow, Monica
AU - Cedillo-Peláez, Carlos
AU - Concha-del-Río, Luz Elena
AU - Cheja-Kalb, Rashel
AU - Salgar-Henao, María José
AU - Orozco-Velasco, Eduardo
AU - Luna-Pastén, Héctor
AU - Gómez-Chávez, Fernando
AU - Ibarra, Antonio
AU - Correa, Dolores
N1 - Publisher Copyright:
© Copyright © 2021 Goldberg-Murow, Cedillo-Peláez, Concha-del-Río, Cheja-Kalb, Salgar-Henao, Orozco-Velasco, Luna-Pastén, Gómez-Chávez, Ibarra and Correa.
PY - 2021/5/12
Y1 - 2021/5/12
N2 - Toxoplasma gondii infection can trigger autoreactivity by different mechanisms. In the case of ocular toxoplasmosis, disruption of the blood-retinal barrier may cause exposure of confined retinal antigens such as recoverin. Besides, cross-reactivity can be induced by molecular mimicry of parasite antigens like HSP70, which shares 76% identity with the human ortholog. Autoreactivity can be a determining factor of clinical manifestations in the eye and in the central nervous system. We performed a prospective observational study to determine the presence of autoantibodies against recoverin and HSP70 by indirect ELISA in the serum of 65 patients with ocular, neuro-ophthalmic and congenital cerebral toxoplasmosis. We found systemic autoantibodies against recoverin and HSP70 in 33.8% and 15.6% of individuals, respectively. The presence of autoantibodies in cases of OT may be related to the severity of clinical manifestations, while in cases with CNS involvement they may have a protective role. Unexpectedly, anti-recoverin antibodies were found in patients with cerebral involvement, without ocular toxoplasmosis; therefore, we analyzed and proved cross-reactivity between recoverin and a brain antigen, hippocalcin, so the immunological phenomenon occurring in one immune-privileged organ (e.g. the central nervous system) could affect the environment of another (egg. the eye).
AB - Toxoplasma gondii infection can trigger autoreactivity by different mechanisms. In the case of ocular toxoplasmosis, disruption of the blood-retinal barrier may cause exposure of confined retinal antigens such as recoverin. Besides, cross-reactivity can be induced by molecular mimicry of parasite antigens like HSP70, which shares 76% identity with the human ortholog. Autoreactivity can be a determining factor of clinical manifestations in the eye and in the central nervous system. We performed a prospective observational study to determine the presence of autoantibodies against recoverin and HSP70 by indirect ELISA in the serum of 65 patients with ocular, neuro-ophthalmic and congenital cerebral toxoplasmosis. We found systemic autoantibodies against recoverin and HSP70 in 33.8% and 15.6% of individuals, respectively. The presence of autoantibodies in cases of OT may be related to the severity of clinical manifestations, while in cases with CNS involvement they may have a protective role. Unexpectedly, anti-recoverin antibodies were found in patients with cerebral involvement, without ocular toxoplasmosis; therefore, we analyzed and proved cross-reactivity between recoverin and a brain antigen, hippocalcin, so the immunological phenomenon occurring in one immune-privileged organ (e.g. the central nervous system) could affect the environment of another (egg. the eye).
KW - autoantibodies
KW - cerebral toxoplasmosis
KW - cross-reactivity
KW - hippocalcin
KW - HSP70
KW - ocular toxoplasmosis
KW - recoverin
KW - Toxoplasma gondii
UR - http://www.scopus.com/inward/record.url?scp=85107022790&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2021.606963
DO - 10.3389/fimmu.2021.606963
M3 - Artículo
C2 - 34054794
AN - SCOPUS:85107022790
SN - 1664-3224
VL - 12
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 606963
ER -